Female carriers of transmembrane and extracellular PLP1 PMD mutations, which tend to cause the most severe cases of PMD in men, have been shown to be less likely to show any clinical manifestations of disease than women carrying mutations in the intracellular domains of PLP [1,3]. The gene discussed is PLP1; the disease is Pelizeaus-Merzbacher spectrum disorder.